Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-08-31 22:11:59 UTC
Update Date2021-09-26 22:48:58 UTC
HMDB IDHMDB0242505
Secondary Accession NumbersNone
Metabolite Identification
Common Name(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
Description(2S,3R,5S)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol, also known as dichlorobenzimidazole riboside or dichlororibofuranosylbenzimidazole, belongs to the class of organic compounds known as benzimidazole ribonucleosides and ribonucleotides. These are nucleosides with a structure that consists of an imidazole moiety of benzimidazole is N-linked to a ribose (or deoxyribose). Nucleotides have a phosphate group linked to the C5 carbon of the ribose (or deoxyribose) moiety. Based on a literature review very few articles have been published on (2S,3R,5S)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol. This compound has been identified in human blood as reported by (PMID: 31557052 ). (2r,3r,4s,5r)-2-(5,6-dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
Dichlorobenzimidazole ribosideHMDB
DichlororibofuranosylbenzimidazoleHMDB
5,6-Dichloro-1-beta-D-ribofuranosyl-1-H-benzimidazolHMDB
5,6 Dichloro 1 beta D ribofuranosyl 1 H benzimidazolHMDB
DRBHMDB
5,6-Dichloro-1-beta-ribofuranosylbenzimidazoleHMDB
5,6 Dichloro 1 beta ribofuranosylbenzimidazoleHMDB
Riboside, dichlorobenzimidazoleHMDB
5,6-Dichloro-1-b-D-ribofuranosylbenzimidazoleGenerator
5,6-Dichloro-1-β-D-ribofuranosylbenzimidazoleGenerator
Chemical FormulaC12H12Cl2N2O4
Average Molecular Weight319.14
Monoisotopic Molecular Weight318.0174123
IUPAC Name2-(5,6-dichloro-1H-1,3-benzodiazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
Traditional Name2-(5,6-dichloro-1,3-benzodiazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol
CAS Registry NumberNot Available
SMILES
OCC1OC(C(O)C1O)N1C=NC2=CC(Cl)=C(Cl)C=C12
InChI Identifier
InChI=1S/C12H12Cl2N2O4/c13-5-1-7-8(2-6(5)14)16(4-15-7)12-11(19)10(18)9(3-17)20-12/h1-2,4,9-12,17-19H,3H2
InChI KeyXHSQDZXAVJRBMX-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzimidazole ribonucleosides and ribonucleotides. These are nucleosides with a structure that consists of an imidazole moiety of benzimidazole is N-linked to a ribose (or deoxyribose). Nucleotides have a phosphate group linked to the C5 carbon of the ribose (or deoxyribose) moiety.
KingdomOrganic compounds
Super ClassNucleosides, nucleotides, and analogues
ClassBenzimidazole ribonucleosides and ribonucleotides
Sub ClassNot Available
Direct ParentBenzimidazole ribonucleosides and ribonucleotides
Alternative Parents
Substituents
  • 1-ribofuranosylbenzimidazole
  • Glycosyl compound
  • N-glycosyl compound
  • Pentose monosaccharide
  • Benzimidazole
  • Aryl chloride
  • Aryl halide
  • Benzenoid
  • Monosaccharide
  • N-substituted imidazole
  • Azole
  • Heteroaromatic compound
  • Imidazole
  • Tetrahydrofuran
  • Secondary alcohol
  • Oxacycle
  • Azacycle
  • Organoheterocyclic compound
  • Organooxygen compound
  • Primary alcohol
  • Organic nitrogen compound
  • Alcohol
  • Hydrocarbon derivative
  • Organopnictogen compound
  • Organic oxygen compound
  • Organohalogen compound
  • Organochloride
  • Organonitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP1.01ALOGPS
logP0.91ChemAxon
logS-2.1ALOGPS
pKa (Strongest Acidic)12.46ChemAxon
pKa (Strongest Basic)5.24ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area87.74 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity71.17 m³·mol⁻¹ChemAxon
Polarizability29.84 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M-2H]-199.2730932474
DeepCCS[M+Na]+174.83530932474
AllCCS[M+H]+168.332859911
AllCCS[M+H-H2O]+165.132859911
AllCCS[M+NH4]+171.332859911
AllCCS[M+Na]+172.132859911
AllCCS[M-H]-165.432859911
AllCCS[M+Na-2H]-165.232859911
AllCCS[M+HCOO]-165.032859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diolOCC1OC(C(O)C1O)N1C=NC2=CC(Cl)=C(Cl)C=C121821.1Standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,1TMS,isomer #1C[Si](C)(C)OCC1OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C(O)C1O2803.9Semi standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,1TMS,isomer #1C[Si](C)(C)OCC1OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C(O)C1O2622.7Standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,1TMS,isomer #1C[Si](C)(C)OCC1OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C(O)C1O4028.7Standard polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,1TMS,isomer #2C[Si](C)(C)OC1C(O)C(CO)OC1N1C=NC2=CC(Cl)=C(Cl)C=C212789.9Semi standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,1TMS,isomer #2C[Si](C)(C)OC1C(O)C(CO)OC1N1C=NC2=CC(Cl)=C(Cl)C=C212562.8Standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,1TMS,isomer #2C[Si](C)(C)OC1C(O)C(CO)OC1N1C=NC2=CC(Cl)=C(Cl)C=C213955.9Standard polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,1TMS,isomer #3C[Si](C)(C)OC1C(CO)OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C1O2814.5Semi standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,1TMS,isomer #3C[Si](C)(C)OC1C(CO)OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C1O2554.2Standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,1TMS,isomer #3C[Si](C)(C)OC1C(CO)OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C1O3922.1Standard polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TMS,isomer #1C[Si](C)(C)OCC1OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C(O[Si](C)(C)C)C1O2738.7Semi standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TMS,isomer #1C[Si](C)(C)OCC1OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C(O[Si](C)(C)C)C1O2649.2Standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TMS,isomer #1C[Si](C)(C)OCC1OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C(O[Si](C)(C)C)C1O3389.2Standard polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TMS,isomer #3C[Si](C)(C)OC1C(CO)OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C1O[Si](C)(C)C2733.4Semi standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TMS,isomer #3C[Si](C)(C)OC1C(CO)OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C1O[Si](C)(C)C2609.3Standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TMS,isomer #3C[Si](C)(C)OC1C(CO)OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C1O[Si](C)(C)C3296.1Standard polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC1C(O)C(CO)OC1N1C=NC2=CC(Cl)=C(Cl)C=C213062.8Semi standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC1C(O)C(CO)OC1N1C=NC2=CC(Cl)=C(Cl)C=C212810.2Standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,1TBDMS,isomer #2CC(C)(C)[Si](C)(C)OC1C(O)C(CO)OC1N1C=NC2=CC(Cl)=C(Cl)C=C213928.5Standard polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OCC1OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C(O[Si](C)(C)C(C)(C)C)C1O3237.5Semi standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OCC1OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C(O[Si](C)(C)C(C)(C)C)C1O3132.5Standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TBDMS,isomer #1CC(C)(C)[Si](C)(C)OCC1OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C(O[Si](C)(C)C(C)(C)C)C1O3482.9Standard polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)OCC1OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C(O)C1O[Si](C)(C)C(C)(C)C3262.6Semi standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)OCC1OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C(O)C1O[Si](C)(C)C(C)(C)C3134.0Standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TBDMS,isomer #2CC(C)(C)[Si](C)(C)OCC1OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C(O)C1O[Si](C)(C)C(C)(C)C3460.9Standard polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC1C(CO)OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C1O[Si](C)(C)C(C)(C)C3271.0Semi standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC1C(CO)OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C1O[Si](C)(C)C(C)(C)C3090.6Standard non polar33892256
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol,2TBDMS,isomer #3CC(C)(C)[Si](C)(C)OC1C(CO)OC(N2C=NC3=CC(Cl)=C(Cl)C=C32)C1O[Si](C)(C)C(C)(C)C3408.4Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol GC-MS (Non-derivatized) - 70eV, Positivesplash10-0adl-9110000000-7aa2c35e1ed29ce3a1b22021-09-23Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol GC-MS (TMS_2_2) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol GC-MS (TMS_3_1) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol GC-MS (TBDMS_1_3) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol GC-MS (TBDMS_3_1) - 70eV, PositiveNot Available2021-11-03Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol 40V, Positive-QTOFsplash10-000i-0900000000-5e18f9a9ea95e7412f192021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol 10V, Negative-QTOFsplash10-001i-0900000000-e52ea19abe014121c3932021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol 20V, Negative-QTOFsplash10-001i-0900000000-566c3b52dc630b47025e2021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol 20V, Positive-QTOFsplash10-000i-0900000000-6d0199209fbdc79cb55d2021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol 10V, Positive-QTOFsplash10-000i-0900000000-aa452379200d146b118a2021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol 40V, Negative-QTOFsplash10-001i-0900000000-e302af9ae78a184c79fa2021-09-20HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol 10V, Positive-QTOFsplash10-000i-0902000000-095afcd56b1453b11f202021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol 20V, Positive-QTOFsplash10-000i-0923000000-6990f005b80fec1d0ec72021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol 40V, Positive-QTOFsplash10-000i-0900000000-51760f105c3e83d7cfa02021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol 10V, Negative-QTOFsplash10-014i-0439000000-bb050c4feb4c3230d3cf2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol 20V, Negative-QTOFsplash10-001i-3791000000-786299725f276e0dd4db2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol 40V, Negative-QTOFsplash10-01q9-5970000000-b3f2608e16da25f9bd282021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID3053
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound3165
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]